Literature DB >> 9501188

High affinity ligands from in vitro selection: complex targets.

K N Morris1, K B Jensen, C M Julin, M Weil, L Gold.   

Abstract

Human red blood cell membranes were used as a model system to determine if the systematic evolution of ligands by exponential enrichment (SELEX) methodology, an in vitro protocol for isolating high-affinity oligonucleotides that bind specifically to virtually any single protein, could be used with a complex mixture of potential targets. Ligands to multiple targets were generated simultaneously during the selection process, and the binding affinities of these ligands for their targets are comparable to those found in similar experiments against pure targets. A secondary selection scheme, deconvolution-SELEX, facilitates rapid isolation of the ligands to targets of special interest within the mixture. SELEX provides high-affinity compounds for multiple targets in a mixture and might allow a means for dissecting complex biological systems.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9501188      PMCID: PMC19667          DOI: 10.1073/pnas.95.6.2902

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  Selection of high-affinity RNA ligands to reverse transcriptase: inhibition of cDNA synthesis and RNase H activity.

Authors:  H Chen; L Gold
Journal:  Biochemistry       Date:  1994-07-26       Impact factor: 3.162

Review 2.  Diversity of oligonucleotide functions.

Authors:  L Gold; B Polisky; O Uhlenbeck; M Yarus
Journal:  Annu Rev Biochem       Date:  1995       Impact factor: 23.643

3.  Toward cell-targeting gene therapy vectors: selection of cell-binding peptides from random peptide-presenting phage libraries.

Authors:  M A Barry; W J Dower; S A Johnston
Journal:  Nat Med       Date:  1996-03       Impact factor: 53.440

4.  Using in vitro selection to direct the covalent attachment of human immunodeficiency virus type 1 Rev protein to high-affinity RNA ligands.

Authors:  K B Jensen; B L Atkinson; M C Willis; T H Koch; L Gold
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-19       Impact factor: 11.205

5.  Isolation of virus-neutralizing RNAs from a large pool of random sequences.

Authors:  W Pan; R C Craven; Q Qiu; C B Wilson; J W Wills; S Golovine; J F Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

Review 6.  Making antibodies by phage display technology.

Authors:  G Winter; A D Griffiths; R E Hawkins; H R Hoogenboom
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

7.  Isolation and characterization of band 3, the predominant polypeptide of the human erythrocyte membrane.

Authors:  J Yu; T L Steck
Journal:  J Biol Chem       Date:  1975-12-10       Impact factor: 5.157

8.  Small peptides as potent mimetics of the protein hormone erythropoietin.

Authors:  N C Wrighton; F X Farrell; R Chang; A K Kashyap; F P Barbone; L S Mulcahy; D L Johnson; R W Barrett; L K Jolliffe; W J Dower
Journal:  Science       Date:  1996-07-26       Impact factor: 47.728

9.  Potent 2'-amino-2'-deoxypyrimidine RNA inhibitors of basic fibroblast growth factor.

Authors:  D Jellinek; L S Green; C Bell; C K Lynott; N Gill; C Vargeese; G Kirschenheuter; D P McGee; P Abesinghe; W A Pieken
Journal:  Biochemistry       Date:  1995-09-12       Impact factor: 3.162

10.  Retention of biological activity following radioiodination of human interleukin 2: comparison with biosynthetically labeled growth factor in receptor binding assays.

Authors:  R J Robb; P C Mayer; R Garlick
Journal:  J Immunol Methods       Date:  1985-07-16       Impact factor: 2.303

View more
  92 in total

1.  Development of DNA aptamers using Cell-SELEX.

Authors:  Kwame Sefah; Dihua Shangguan; Xiangling Xiong; Meghan B O'Donoghue; Weihong Tan
Journal:  Nat Protoc       Date:  2010-06-03       Impact factor: 13.491

2.  Cell-penetrating RNAs: new keys to the castle.

Authors:  Donald H Burke
Journal:  Mol Ther       Date:  2012-02       Impact factor: 11.454

3.  Aptamers evolved from live cells as effective molecular probes for cancer study.

Authors:  Dihua Shangguan; Ying Li; Zhiwen Tang; Zehui Charles Cao; Hui William Chen; Prabodhika Mallikaratchy; Kwame Sefah; Chaoyong James Yang; Weihong Tan
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-27       Impact factor: 11.205

Review 4.  Drug delivery systems in urology--getting "smarter".

Authors:  Omid C Farokhzad; Jordan D Dimitrakov; Jeffrey M Karp; Ali Khademhosseini; Michael R Freeman; Robert Langer
Journal:  Urology       Date:  2006-09       Impact factor: 2.649

5.  Micromagnetic selection of aptamers in microfluidic channels.

Authors:  Xinhui Lou; Jiangrong Qian; Yi Xiao; Lisan Viel; Aren E Gerdon; Eric T Lagally; Paul Atzberger; Theodore M Tarasow; Alan J Heeger; H Tom Soh
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-06       Impact factor: 11.205

Review 6.  Cell-specific aptamers for targeted therapies.

Authors:  Laura Cerchia; Paloma H Giangrande; James O McNamara; Vittorio de Franciscis
Journal:  Methods Mol Biol       Date:  2009

Review 7.  Aptamers and the next generation of diagnostic reagents.

Authors:  Varatharasa Thiviyanathan; David G Gorenstein
Journal:  Proteomics Clin Appl       Date:  2012-12       Impact factor: 3.494

8.  Label-free fluorescent aptamer sensor based on regulation of malachite green fluorescence.

Authors:  Weichen Xu; Yi Lu
Journal:  Anal Chem       Date:  2010-01-15       Impact factor: 6.986

9.  Aptamer-nanoparticle strip biosensor for sensitive detection of cancer cells.

Authors:  Guodong Liu; Xun Mao; Joseph A Phillips; Hui Xu; Weihong Tan; Lingwen Zeng
Journal:  Anal Chem       Date:  2009-12-15       Impact factor: 6.986

Review 10.  Targeting stem cells-clinical implications for cancer therapy.

Authors:  Lan Chun Tu; Greg Foltz; Edward Lin; Leroy Hood; Qiang Tian
Journal:  Curr Stem Cell Res Ther       Date:  2009-05       Impact factor: 3.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.